E
enGene Therapeutics Inc. (ENGN)
NCM – Real Time Price. Currency in USD
1.44
-0.05 (-3.36%)
At close: May 12, 2026, 4:00 PM EDT
1.48
+0.04 (2.75%)
After-hours: May 12, 2026, 7:57 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
1.44
-0.05 (-3.36%)
At close: May 12, 2026, 4:00 PM EDT
1.48
+0.04 (2.75%)
After-hours: May 12, 2026, 7:57 PM EDT
enGene Therapeutics Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company in Canada. The company develops genetic medicines to help patients suffering from bladder cancer. Its lead product candidate is detalimogene voraplasmid, a monotherapy for the treatment of non-muscle invasive bladder cancer (NMIBC). Its pipeline includes LEGEND, which is in Phase 2. The company was formerly known as enGene Holdings Inc. and changed its name to enGene Therapeutics Inc. in April 2026. enGene Therapeutics Inc. is based in Montreal, Canada.
| Name | Position |
|---|---|
| Dr. Alexander Nichols Ph.D. | Chief Strategy & Operations Officer |
| Dr. Anthony T. Cheung Ph.D. | Co-Founder & Chief Scientific Officer |
| Dr. Hussein Sweiti M.D., M.Sc. | Chief Medical Officer and Head of Research & Development |
| Mr. David Ryan Daws | CFO & Head of Business Development |
| Mr. Lee G. Giguere | Chief Legal Officer & Corporate Secretary |
| Mr. Matthew Boyd | Chief Regulatory Officer |
| Date | Type | Document |
|---|---|---|
| 2026-05-08 | ARS | ef20072042_ars.pdf |
| 2026-05-07 | 8-K | d335486d8k.htm |
| 2026-04-09 | 8-K | engn-20260407.htm |
| 2026-03-09 | S-8 | engn-20260309.htm |
| 2026-02-26 | CORRESP | filename1.htm |
| 2026-02-19 | S-3 | engn-20260219.htm |
| 2026-02-19 | 10-K/A | engn-20251031.htm |
| 2026-01-21 | 8-K | engn-20260120.htm |
| 2025-12-22 | 8-K | engn-20251222.htm |
| 2025-12-22 | 10-K | engn-20251031.htm |
| Mr. Ronald H. W. Cooper | President, CEO & Director |
| Ms. Jill Buck | Chief Development Officer |
| Ms. Joan Connolly | Chief Technology Officer |
| Ms. Tara Place M.B.A. | Senior VP of Human Resources |